NEAT 022: Switch From Boosted PI–Based ART to Dolutegravir-Based ART Maintains Virologic Suppression, Improves Lipid Profile in Virologically Suppressed Patients With High CVD Risk
Choosing Statins for Patients With Dyslipidemia and Elevated CVD Risk
Clinical Impact of New Data From IAS 2017
Key Studies Influencing My Practice Following IAS 2017
ZEST: Greater Improvements in Bone Mineral Density With Zoledronic Acid vs Switch From TDF in HIV-Infected Osteopenic Men on Stable TDF-Containing ART Over 2 Years
Clinical Care Options, LLC. All Rights Reserved.